These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26794527)

  • 1. Imaging organelle transport in primary hippocampal neurons treated with amyloid-β oligomers.
    Gan KJ; Silverman MA
    Methods Cell Biol; 2016; 131():425-51. PubMed ID: 26794527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid-β oligomers induce tau-independent disruption of BDNF axonal transport via calcineurin activation in cultured hippocampal neurons.
    Ramser EM; Gan KJ; Decker H; Fan EY; Suzuki MM; Ferreira ST; Silverman MA
    Mol Biol Cell; 2013 Aug; 24(16):2494-505. PubMed ID: 23783030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live cell imaging of cytoplasmic dynein movement in transfected embryonic rat neurons.
    Ross MW; Mitchell DJ; Cain JC; Blasier KR; Pfister KK
    Methods Cell Biol; 2016; 131():253-67. PubMed ID: 26794518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of insulin signaling rescues BDNF transport defects independent of tau in amyloid-β oligomer-treated hippocampal neurons.
    Takach O; Gill TB; Silverman MA
    Neurobiol Aging; 2015 Mar; 36(3):1378-82. PubMed ID: 25543463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular amyloid β oligomers impair organelle transport and induce dendritic spine loss in primary neurons.
    Umeda T; Ramser EM; Yamashita M; Nakajima K; Mori H; Silverman MA; Tomiyama T
    Acta Neuropathol Commun; 2015 Aug; 3():51. PubMed ID: 26293809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-beta peptide oligomers disrupt axonal transport through an NMDA receptor-dependent mechanism that is mediated by glycogen synthase kinase 3beta in primary cultured hippocampal neurons.
    Decker H; Lo KY; Unger SM; Ferreira ST; Silverman MA
    J Neurosci; 2010 Jul; 30(27):9166-71. PubMed ID: 20610750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of axonal transport markers in primary mammalian neurons.
    Klinman E; Holzbaur EL
    Methods Cell Biol; 2016; 131():409-24. PubMed ID: 26794526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid beta-mediated KIF5A deficiency disrupts anterograde axonal mitochondrial movement.
    Wang Q; Tian J; Chen H; Du H; Guo L
    Neurobiol Dis; 2019 Jul; 127():410-418. PubMed ID: 30923004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau reduction prevents Abeta-induced defects in axonal transport.
    Vossel KA; Zhang K; Brodbeck J; Daub AC; Sharma P; Finkbeiner S; Cui B; Mucke L
    Science; 2010 Oct; 330(6001):198. PubMed ID: 20829454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo analysis of axonal transport in zebrafish.
    Drerup CM; Nechiporuk AV
    Methods Cell Biol; 2016; 131():311-29. PubMed ID: 26794521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axonal stress kinase activation and tau misbehavior induced by kinesin-1 transport defects.
    Falzone TL; Stokin GB; Lillo C; Rodrigues EM; Westerman EL; Williams DS; Goldstein LS
    J Neurosci; 2009 May; 29(18):5758-67. PubMed ID: 19420244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging amyloid precursor protein in vivo: an axonal transport assay.
    Falzone TL; Stokin GB
    Methods Mol Biol; 2012; 846():295-303. PubMed ID: 22367820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linking amyloid-β and tau: amyloid-β induced synaptic dysfunction via local wreckage of the neuronal cytoskeleton.
    Zempel H; Mandelkow EM
    Neurodegener Dis; 2012; 10(1-4):64-72. PubMed ID: 22156588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic and axonal mechanisms of Ca2+ elevation impair BDNF transport in Aβ oligomer-treated hippocampal neurons.
    Gan KJ; Silverman MA
    Mol Biol Cell; 2015 Mar; 26(6):1058-71. PubMed ID: 25609087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of potential mechanisms of amyloid-induced defects in neuronal transport.
    Shah SB; Nolan R; Davis E; Stokin GB; Niesman I; Canto I; Glabe C; Goldstein LS
    Neurobiol Dis; 2009 Oct; 36(1):11-25. PubMed ID: 19497367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-beta-derived diffusible ligands cause impaired axonal transport of mitochondria in neurons.
    Wang X; Perry G; Smith MA; Zhu X
    Neurodegener Dis; 2010; 7(1-3):56-9. PubMed ID: 20160460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live-cell imaging of retrograde transport initiation in primary neurons.
    Nirschl JJ; Holzbaur EL
    Methods Cell Biol; 2016; 131():269-76. PubMed ID: 26794519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau
    Afreen S; Riherd Methner DN; Ferreira A
    Neuroscience; 2017 Oct; 362():104-117. PubMed ID: 28844006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau reduction prevents Aβ-induced axonal transport deficits by blocking activation of GSK3β.
    Vossel KA; Xu JC; Fomenko V; Miyamoto T; Suberbielle E; Knox JA; Ho K; Kim DH; Yu GQ; Mucke L
    J Cell Biol; 2015 May; 209(3):419-33. PubMed ID: 25963821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atlas stumbled: kinesin light chain-1 variant E triggers a vicious cycle of axonal transport disruption and amyloid-β generation in Alzheimer's disease.
    Gan KJ; Morihara T; Silverman MA
    Bioessays; 2015 Feb; 37(2):131-41. PubMed ID: 25394182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.